These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 29144719)

  • 1. Real-world health plan claims analysis of differences in healthcare utilization and total cost in patients suffering from cluster headaches and those without headache-related conditions.
    Polson M; Lord TC; Evangelatos TM; Lopes M; Santaniello BL
    Am J Manag Care; 2017 Nov; 23(16 Suppl):S295-S299. PubMed ID: 29144719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data.
    Choong CK; Ford JH; Nyhuis AW; Robinson RL; Aurora SK
    J Manag Care Spec Pharm; 2018 Sep; 24(9):921-928. PubMed ID: 30156448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant medical conditions and total cost of care in patients with migraine: a real-world claims analysis.
    Polson M; Williams TD; Speicher LC; Mwamburi M; Staats PS; Tenaglia AT
    Am J Manag Care; 2020 Feb; 26(1 Suppl):S3-S7. PubMed ID: 32109018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data.
    Choong CK; Ford JH; Nyhuis AW; Joshi SG; Robinson RL; Aurora SK; Martinez JM
    Headache; 2017 Oct; 57(9):1359-1374. PubMed ID: 28581025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization.
    Mitchell MP; Schaecher K; Cannon HE; Speckman M
    J Manag Care Pharm; 2008 Jun; 14(5):442-50. PubMed ID: 18597573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Societal burden of cluster headache in the United States: a descriptive economic analysis.
    Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
    J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.
    Asche CV; Singer ME; Jhaveri M; Chung H; Miller A
    J Manag Care Pharm; 2010; 16(9):703-12. PubMed ID: 21067256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.
    Bhowmik D; Hines DM; Intorcia M; Wade RL
    J Med Econ; 2018 Jun; 21(6):622-628. PubMed ID: 29571273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of sarcoidosis in a commercially-insured population in the United States.
    Rice JB; White A; Lopez A; Conway A; Wagh A; Nelson WW; Philbin M; Wan GJ
    J Med Econ; 2017 Oct; 20(10):1048-1055. PubMed ID: 28678623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect costs of cluster headache: a prospective analysis in a tertiary level headache centre.
    Negro A; Sciattella P; Spuntarelli V; Martelletti P; Mennini FS
    J Headache Pain; 2020 May; 21(1):44. PubMed ID: 32366217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data.
    Margolis J; Barron JJ; Grochulski WD
    J Manag Care Pharm; 2005; 11(9):727-34. PubMed ID: 16300416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare resource utilization and costs associated with hepatitis A in the United States: a retrospective database analysis.
    Samant S; Chen E; Carias C; Kujawski SA
    J Med Econ; 2024; 27(1):1046-1052. PubMed ID: 39092467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare resource utilization and costs by age and joint location among osteoarthritis patients in a privately insured population.
    Wang SX; Ganguli AX; Bodhani A; Medema JK; Reichmann WM; Macaulay D
    J Med Econ; 2017 Dec; 20(12):1299-1306. PubMed ID: 28880733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comorbidity burden of patients with cluster headache: a population-based study.
    Joshi S; Rizzoli P; Loder E
    J Headache Pain; 2017 Dec; 18(1):76. PubMed ID: 28741257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care utilization patterns and costs for patients with hidradenitis suppurativa.
    Kirby JS; Miller JJ; Adams DR; Leslie D
    JAMA Dermatol; 2014 Sep; 150(9):937-44. PubMed ID: 24908260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics.
    Baser O; Xie L; Pesa J; Durkin M
    J Med Econ; 2015 May; 18(5):357-65. PubMed ID: 25525771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.